Home › Chronic Myelomonocytic Leukemia › Minnesota › Rochester
Chronic Myelomonocytic Leukemia clinical trials in Rochester, MN
6 studies for Chronic Myelomonocytic Leukemia are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
RecruitingPhase 2
- Mayo Clinic in Rochester, Rochester
Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
RecruitingPhase 2
- Mayo Clinic Rochester, Rochester
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
RecruitingObservational study
- Mayo Clinic Rochester, Rochester
Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
RecruitingPhase 1
- Mayo Clinic in Rochester, Rochester
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
RecruitingPhase 1
- Mayo Clinic, Rochester
Q702 for the Treatment of Patients With Hematologic Malignancies
RecruitingPhase 1
- Mayo Clinic in Rochester, Rochester
Chronic Myelomonocytic Leukemia trials in other cities
- Houston, TX16 studies
- Seattle, WA10 studies
- Boston, MA7 studies
- Mountain View, CA6 studies
- Baldwin Park, CA6 studies
- New York City, NY6 studies
- Durham, NC5 studies
- Miami, FL4 studies
- Tampa, FL4 studies
- Birmingham, AL4 studies
- Columbus, OH4 studies
- Atlanta, GA4 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer37 studies
- Metastatic Cancer31 studies
- Cancer (all types)30 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Multiple Myeloma24 studies
- Heart Failure22 studies
- Prostate Cancer22 studies
- Pancreatic Cancer22 studies
- Endometrial Cancer20 studies
- Lung Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.